Albert Einstein College of Medicine-Montefiore Medical Center and Medscape, LLC require every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

Disclosures for additional planners can be found here.

Faculty

Jean M. Elwing, MD

Professor of Clinical Internal Medicine
University of Cincinnati
Cincinnati, Ohio

Disclosures

Jean M. Elwing, MD, has the following relevant financial relationships:
Consultant or advisor for: Aerovate; Altavant; Bayer; Gossamer Bio; United Therapeutics
Research funding from: Acceleron; Aerovate; Altavant; Bayer; Gossamer Bio; Janssen; Liquidia; Phase Bio; United Therapeutics

Martha Kingman, FNP-C, DNP

Family Nurse Practitioner
Pulmonary Hypertension Clinic
University of Texas Southwestern Medical Center
Dallas, Texas

Disclosures

Martha Kingman, FNP-C, DNP, has the following relevant financial relationships:
Consultant or advisor for: Aerovate; Bayer; Gossamer Bio; Janssen; Johnson & Johnson; Liquidia; Merck; United Therapeutics

Josanna Rodriguez-Lopez, MD

Director, Pulmonary Hypertension and CTEPH Program
Director, Hereditary Hemorrhagic Telangiectasia Center
Massachusetts General Hospital
Boston, Massachusetts

Disclosures

Josanna Rodriguez-Lopez, MD, has the following relevant financial relationships:
Consultant or advisor for: Altavant; Bayer; United Therapeutics
Research funding from: Bayer; Merck; United Therapeutics

Vallerie V. McLaughlin, MD

Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
Director
Pulmonary Hypertension Program
University of Michigan
Ann Arbor, Michigan

Disclosures

Vallerie V. McLaughlin, MD, has the following relevant financial relationships:
Consultant or advisor for: Acceleron; Actelion; Aerovate; Altavant; Bayer; Caremark; Gossamer Bio; Liquidia; Merck; United Therapeutics
Research funding from: Acceleron; Actelion; Altavant; Reata; Sonvie
Stock options from: Clene

Editor

Asha P. Gupta, PharmD, RPh

Medical Education Director, Medscape, LLC

Disclosures

Asha P. Gupta, PharmD, RPh, has no relevant financial relationships.

Compliance Reviewer

Yaisanet Oyola, MD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Yaisanet Oyola, MD, has no relevant financial relationships.

Sandhya Murthy, MD

CME Reviewer, Montefiore Medical Center

Disclosures

Sandhya Murthy, MD, has disclosed no relevant financial relationships with ineligible companies in the last 24 months.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

CME

Pulmonary Arterial Hypertension in the Modern World: Approaches to Enhance Diagnosis and Treatment

Authors: Jean M. Elwing, MD; Martha Kingman, FNP-C, DNP; Josanna Rodriguez-Lopez, MD; Vallerie V. McLaughlin, MD
CME Released: 11/15/2022
Valid for credit through: 11/15/2023

Start Activity

Credits Available

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

You Are Eligible For
- Letter of Completion

Target Audience and Goal Statement

This activity is intended for cardiologists, pulmonologists, and primary care physicians.

The goal of this activity is for learners to be better able to improve recognition, diagnosis, and treatment of PAH.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Guideline recommendations for the diagnosis and treatment of PAH
Have greater competence related to
- Use of evidence-based strategies to escalate therapy in appropriate patients with PAH who are not meeting treatment goals
- Use of effective strategies to educate patients on the importance of therapy adherence to delay disease progression and improve outcomes

Disclosures

Disclosures for additional planners can be found here.

Faculty

Jean M. Elwing, MD

Professor of Clinical Internal Medicine
University of Cincinnati
Cincinnati, Ohio

Disclosures

Jean M. Elwing, MD, has the following relevant financial relationships:
Consultant or advisor for: Aerovate; Altavant; Bayer; Gossamer Bio; United Therapeutics
Research funding from: Acceleron; Aerovate; Altavant; Bayer; Gossamer Bio; Janssen; Liquidia; Phase Bio; United Therapeutics

Martha Kingman, FNP-C, DNP

Family Nurse Practitioner
Pulmonary Hypertension Clinic
University of Texas Southwestern Medical Center
Dallas, Texas

Disclosures

Martha Kingman, FNP-C, DNP, has the following relevant financial relationships:
Consultant or advisor for: Aerovate; Bayer; Gossamer Bio; Janssen; Johnson & Johnson; Liquidia; Merck; United Therapeutics

Josanna Rodriguez-Lopez, MD

Director, Pulmonary Hypertension and CTEPH Program
Director, Hereditary Hemorrhagic Telangiectasia Center
Massachusetts General Hospital
Boston, Massachusetts

Disclosures

Josanna Rodriguez-Lopez, MD, has the following relevant financial relationships:
Consultant or advisor for: Altavant; Bayer; United Therapeutics
Research funding from: Bayer; Merck; United Therapeutics

Vallerie V. McLaughlin, MD

Kim A. Eagle, MD, Endowed Professor of Cardiovascular Medicine
Director
Pulmonary Hypertension Program
University of Michigan
Ann Arbor, Michigan

Disclosures

Vallerie V. McLaughlin, MD, has the following relevant financial relationships:
Consultant or advisor for: Acceleron; Actelion; Aerovate; Altavant; Bayer; Caremark; Gossamer Bio; Liquidia; Merck; United Therapeutics
Research funding from: Acceleron; Actelion; Altavant; Reata; Sonvie
Stock options from: Clene

Editor

Asha P. Gupta, PharmD, RPh

Medical Education Director, Medscape, LLC

Disclosures

Asha P. Gupta, PharmD, RPh, has no relevant financial relationships.

Compliance Reviewer

Yaisanet Oyola, MD

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Yaisanet Oyola, MD, has no relevant financial relationships.

Sandhya Murthy, MD

CME Reviewer, Montefiore Medical Center

Disclosures

Sandhya Murthy, MD, has disclosed no relevant financial relationships with ineligible companies in the last 24 months.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.

Accreditation Statements

Developed through a partnership between Medscape and Albert Einstein College of Medicine, Montefiore Medical Center.

In support of improving patient care, Albert Einstein College of Medicine -Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

Read about the target audience, learning objectives, and author disclosures.
Study the educational content online or print it out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

From Medscape Education Cardiology

CME

Pulmonary Arterial Hypertension in the Modern World: Approaches to Enhance Diagnosis and Treatment

Authors: Jean M. Elwing, MD; Martha Kingman, FNP-C, DNP; Josanna Rodriguez-Lopez, MD; Vallerie V. McLaughlin, MDFaculty and Disclosures

CME Released: 11/15/2022

Valid for credit through: 11/15/2023

processing....

Learning Feedback Questions

Online Patient Education
Clinician Handout

Please answer these questions to complement your learning experience.

Page 1 of 4

CME Information

Full Live Event Audio

PDF Downloads

Print
Like Tweet

Full Live Event Audio

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred.

The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

Faculty and Disclosures

Faculty

Jean M. Elwing, MD​

Martha Kingman, FNP-C, DNP

Josanna Rodriguez-Lopez, MD

Vallerie V. McLaughlin, MD

Editor

Asha P. Gupta, PharmD, RPh

Compliance Reviewer

Yaisanet Oyola, MD

Sandhya Murthy, MD

Peer Reviewer

CME

Pulmonary Arterial Hypertension in the Modern World: Approaches to Enhance Diagnosis and Treatment

Credits Available

You Are Eligible For

Target Audience and Goal Statement

Disclosures

Faculty

Jean M. Elwing, MD​

Martha Kingman, FNP-C, DNP

Josanna Rodriguez-Lopez, MD

Vallerie V. McLaughlin, MD

Editor

Asha P. Gupta, PharmD, RPh

Compliance Reviewer

Yaisanet Oyola, MD

Sandhya Murthy, MD

Peer Reviewer

Accreditation Statements

For Physicians

Instructions for Participation and Credit

Pulmonary Arterial Hypertension in the Modern World: Approaches to Enhance Diagnosis and Treatment

Learning Feedback Questions

Online Patient Education Clinician Handout

PDF Downloads

Jean M. Elwing, MD

Jean M. Elwing, MD

Online Patient Education
Clinician Handout